Estimation of Galectin-1 and Runx2 in generalized periodontitis and diabetes
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2023/03/050958
- Lead Sponsor
- Bhavana Vunnam
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
1. Age group 35-75 years.
2. Patients who have not received
any periodontal treatment in previous six months.
3. Patients diagnosed with T2DM as per American Diabetes Association criteria (2019).
4. Patients with a diagnosis of generalized periodontitis as per World Workshop Classification criteria (2017).
1.Smokers and alcoholics.
2.Patients with systemic diseases like hypertension, cardiovascular diseases, rheumatoid arthritis, tumours, autoimmune diseases and renal diseases.
3.Pregnant, lactating females and post menopausal women.
4.Any other systemic disease which can alter the course of periodontal disease.
5.Patients on medications like anti-inflammatory drugs, antibiotics and anti-epileptic drugs in the past 6 months.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method comparatively evaluate salivary and serum levels <br/ ><br>of Galectin-1 and Runx2 in generalized periodontitis and T2DM. <br/ ><br>Explore any correlation of Galectin-1 with Runx2 levels and clinical parameters <br/ ><br>Timepoint: Baseline
- Secondary Outcome Measures
Name Time Method not applicableTimepoint: not applicable